Gene expression profiling identified ROR1, a receptor tyrosine kinase predominantly expressed in embryogenesis [10], as a signature gene in chronic lymphocytic leukemia (CLL) [11], [12], which we and others confirmed by a comprehensive analysis of ROR1 protein expression [13]–[15]. This evidence concerns the gene NTRK1 and B-cell chronic lymphocytic leukemia.